IDXX

In the past six months, IDEXX Laboratories' stock experienced an all-time high closing price of $766.68 on November 25, 2025. On February 2, 2026, the company reported its fourth-quarter and full-year 2025 results, showing 14% reported revenue growth and 12% organic growth. In January 2026, Jonathan Jay Mazelsky became President and CEO. On May 5, 2026, IDEXX announced its first-quarter 2026 results, reporting diluted earnings per share of $3.47 and revenue rising 14% to $1.14 billion. The company raised its full-year 2026 profit and revenue outlook. As of May 8, 2026, the stock price was $560.11, down around 15% year-to-date.